Charles Mullighan, Deputy Director, Comprehensive Cancer Center and William E. Evans Endowed Chair at St. Jude Children’s Research Hospital, shared Trends in Cancer’s post on LinkedIn, adding:
“Glad to have had the opportunity to review the role of fusion oncoproteins and nuclear condensates in leukemia.
Much learned from NUP98-rearranged leukemia, but much still to learn in these hallmark drivers of acute leukemia in children.”
Quoting Trends in Cancer’s post:
“Now online at Trends in Cancer, Nicole Michmerhuizen, PhD, Richard Kriwacki and Charles Mullighan outline the biology and therapeutic potential of fusion oncoprotein-associated condensates in leukemia.”
Title: Condensates in fusion oncoprotein-driven leukemia: new biology and therapeutic opportunities
Authors: Nicole L. Michmerhuizen, Richard W. Kriwacki, Charles G. Mullighan
Other articles featuring Charles Mullighan and Trends in Cancer on Oncodaily.